Teva meets profit expectations but misses on revenue - Globes
Teva targets sub-Saharan Africa - Globes
TEVA Aktienhandel - Steigern Sie Ihre Trades | AvaTrade
Teva apuesta por el África subsahariana
TEVA Aktienkurs und Chart — TASE:TEVA — TradingView
Teva arzneimittel -Fotos und -Bildmaterial in hoher Auflösung – Alamy
Teva share price jumps 55% in past three weeks - גלובס
Sun: TASE opens week higher - Globes
Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug Development and Chronic Disease Management with
Berkovish Branding & Web Design Studio.
Los analistas ven un alza en la cotización de Teva
Teva Pharmaceutical Industries. Emittenten-Informationen. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). Nachrichten und Credit Rating. Finanztabellen von Unternehmen.
Teva Pharmaceuticals and IBM Partner to Build Global e-Health Solutions on the IBM Watson Health Cloud
Teva announces FDA approval for asthma injection, Cinqair | Pharmafile
Teva Announces Launch of Generic Gleevec Tablets in U.S. - Drug Discovery and Development
CSRWire - Teva Continues to Advance Care for Society's Health and Wellbeing; 2016 Social Impact Report Released
Teva launches Copaxone with the YpsoMate autoinjector from Ypsomed - Ypsomed - Österreich
Teva beats analysts on Q4 profit, misses on revenue - Globes
CSRWire - Teva Highlights Key Milestones Achieved in the 2017 Social Impact Report